DCM Shriram Fine Chemicals
DCM Shriram Fine Chemicals (DSFCL) share price was ₹24.82 at the 28 Oct 2026 close; market capitalisation ₹216 Cr; sector Commodities. In the Jun 2026 quarter, revenue fell 8.0% year on year to ₹90.78 Cr and net profit fell 41.4% year on year to ₹2.42 Cr (compared with Jun 2025). Promoters held 50.11% of DCM Shriram Fine Chemicals in Sep 2026, unchanged from Jun 2026.
Key Fundamentals
MicrocapPrice-based figures as of 29 Oct 2026, 10:56 IST · EPS basis: Consolidated · TTM
Peer Comparison
Commodities › Chemicals & Petrochemicals › Specialty Chemicals
| ₹1,362.00 | 52.34 | 1,38,635 Cr | 12.81 | 1.48% | 22.36% | 28.48% | 15,689 Cr | 2,677 Cr | |
| ₹4,246.40 | 77.10 | 46,647 Cr | 5.97 | 0.07% | 7.25% | 10.13% | 5,334 Cr | 600 Cr | |
| ₹8,352.00 | 54.22 | 42,839 Cr | 10.78 | 0.18% | 16.70% | 18.66% | 3,734 Cr | 789 Cr | |
| ₹1,581.20 | 89.18 | 20,987 Cr | 8.55 | 0.00% | 8.94% | 12.15% | 1,257 Cr | 235 Cr | |
| ₹1,486.90 | 25.89 | 20,280 Cr | 3.47 | 0.52% | 9.38% | 10.85% | 8,624 Cr | 784 Cr | |
| ₹460.30 | 31.44 | 16,690 Cr | 2.80 | 0.23% | 7.04% | 8.53% | 9,040 Cr | 531 Cr | |
| ₹5,146.00 | 19.63 | 15,151 Cr | 2.30 | 0.55% | 10.95% | 13.54% | 7,185 Cr | 788 Cr | |
DCM Shriram Fine Chemicals (this company) | ₹25.90 | — | 225 Cr | 1.07 | 1.57% | -1.68% | -0.74% | 378 Cr | -6 Cr |
| Median 8 companies | ₹1,534.05 | 52.34 | 20,634 Cr | 4.72 | 0.38% | 9.16% | 11.50% | 6,260 Cr | 692 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.
Tapetide Score
Data-driven rating, 0–100. How it works →
No Tapetide Score has been computed for this stock yet.
Key Insights
Strengths
1- Company is almost debt free.
Weaknesses
2- Company has low interest coverage ratio.
- Earnings include an other income of Rs.2.31 Cr.
Technical Indicators
Oscillators
Bullish
Overall
Bearish
Moving Averages
Bearish
Growth Rate
change over 1 year
change over 1 year
change over 1 year
change over 1 year Operating margin 5.62% · Jun 2026
Quarterly Results
| Particulars | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|
| Sales | 93.35 | 113 | 98.62 | 96.9 | 96.95 | 93.08 | 90.78 |
| Expenses | 88.47 | 105 | 91.29 | 98.39 | 96.63 | 95.58 | 85.68 |
| Operating Profit | 4.88 | 7.92 | 7.33 | -1.49 | 0.32 | -2.5 | 5.1 |
| OPM % | 5.23% | 7% | 7.43% | -1.54% | 0.33% | -2.69% | 5.62% |
| Other Income | 0.72 | 0.75 | 0.67 | 0.42 | 0.64 | 0.43 | 0.82 |
| Interest | 0.41 | 0.79 | 0.29 | 0.22 | 0.24 | 0.69 | 0.44 |
| Depreciation | 2.2 | 2.16 | 2.16 | 2.17 | 2.11 | 2.06 | 1.95 |
| PBT | 2.99 | 5.72 | 5.55 | -3.46 | -1.39 | -4.82 | 3.53 |
| Tax % | 26.42% | 25.35% | 25.41% | -21.39% | 16.55% | -15.35% | 31.44% |
| Net Profit | 2.2 | 4.27 | 4.13 | -2.72 | -1.62 | -4.08 | 2.42 |
| EPS (₹) | 0.22 | 0.43 | 0.41 | -0.27 | -0.19 | -0.47 | 0.28 |
Profit & Loss
| Particulars | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|
| Sales | 429 | 386 | 378 |
| Expenses | 396 | 379 | 376 |
| Operating Profit | 33 | 7 | 1 |
| OPM % | 8% | 1.8% | 0.4% |
| Other Income | 3 | -1 | 2 |
| Interest | 2 | 1 | 2 |
| Depreciation | 9 | 8 | 8 |
| PBT | 25 | -4 | -6 |
| Tax % | 26% | 4% | — |
| Net Profit | 18 | -4 | -6 |
| EPS (₹) | 1.85 | -0.49 | -0.65 |
| Div. Payout % | 0% | -81% | — |
Balance Sheet
| Particulars | Mar 2025 | Mar 2026 |
|---|---|---|
| Equity Capital | 0 | 17 |
| Reserves | 205 | 183 |
| Borrowings | 13 | 13 |
| Other Liabilities | 80 | 72 |
| Total Liabilities | 298 | 285 |
| Fixed Assets | 131 | 103 |
| CWIP | 0 | 0 |
| Investments | 27 | 38 |
| Other Assets | 140 | 143 |
| Total Assets | 298 | 285 |
Cash Flow
| Particulars | Mar 2025 | Mar 2026 |
|---|---|---|
| Operating | 15 | 16 |
| Investing | 0 | 10 |
| Financing | -15 | -6 |
| Net Cash Flow | 0 | 21 |
| Free Cash Flow | 12 | 36 |
| CFO/OP | 72 | 293 |
Ratios
| Particulars | Mar 2025 | Mar 2026 |
|---|---|---|
| Debtor Days | 70 | 67 |
| Inventory Days | 74 | 64 |
| Days Payable | 80 | 78 |
| Cash Conversion Cycle | 65 | 53 |
| Working Capital Days | 52 | 46 |
| ROCE % | — | 0% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view DCM Shriram Fine Chemicals insights
34 extracted metrics + investor summaries across FY24–FY27.
Documents
Frequently Asked Questions about DCM Shriram Fine Chemicals
What does DCM Shriram Fine Chemicals Ltd do?
Where is DCM Shriram Fine Chemicals Ltd (DSFCL) listed?
Which sector does DCM Shriram Fine Chemicals Ltd belong to?
What is the market capitalisation of DCM Shriram Fine Chemicals Ltd?
What is the 52-week high and low of DCM Shriram Fine Chemicals Ltd?
Does DCM Shriram Fine Chemicals Ltd pay dividends?
What is the Return on Equity (ROE) of DCM Shriram Fine Chemicals Ltd?
Company Information
DCM Shriram Ltd is a producer of Pharmaceutical Intermediates, particularly in the Anti-Infective segment using Optical Isomer separation as its core competence.[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/544703.md for DCM Shriram Fine Chemicals Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.